LINEBURG


<< . .

 85
( 87)



. . >>

Noonan syndrome, 147 pheochromocytoma, 285 liver transplantation, 394
obstetric palsies, 219 thyrotoxic crisis management, 276 Marfan syndrome, 67




430
Index


pheochromocytoma, 284 foramen magnum stenosis, achondroplasia, 108, liver disease emergencies, 257
primary pulmonary hypertension, 59 110, 119“20 malignant bone marrow disorders, 302
ferritin, pregnancy, effects of, 294 Forbes disease, 240 malignant hyperthermia, 270“1
fetal abnormalities forced expiratory volume in one second (FEV1), Marfan syndrome, 68
acute fatty liver of pregnancy, 254 heart“lung transplantation, 388 May“Hegglin anomaly, 306
chronic spinal cord injury, 192 forced vital capacity see FVC (forced vital capacity) McArdle disease, 239
phenylketonuria, 241 formoterol, chronic asthma therapy, 78 mitral regurgitation/insufficiency, 9, 10
fetal cardiac rhabdomyomas, 150 Friedreich ataxia, 155“7, 185, 202 mitral stenosis, 7“8
fetal dysrhythmias, electroconvulsive therapy, 368 epidural analgesia/anesthesia, 167“89 myasthenia gravis see myasthenia gravis (MG)
fetal magnetocardiography, 53 fulminant subacute sclerosing panencephalitis, 182 myotonia congenita, 108, 118
fetal monitoring functional residual capacity (FRC) myotonic dystrophy, 104, 117
malignancy, 371 dwarfism, 116 neurofibromatosis, 149, 218
systemic lupus erythematosus, 412 heart“lung transplantation, 388 osteogenesis imperfecta, 162, 163
fetal mortality scoliosis, 132, 140 paroxysmal nocturnal hemoglobinuria, 299
antiphospholipid syndrome, 419 furosemide, 179 peripartum cardiomyopathy, 12
diabetic ketoacidosis, 278 FVC (forced vital capacity) peripartum ischemic heart disease, 15
´
idiopathic/immune thrombocytopenic Guillain“Barre syndrome, 218 pheochromocytoma, 284“5
purpura, 304 heart“lung transplantation, 388 pneumothorax, 93
parvovirus B19 infection, 327 porphyria, 245
fetal risks gabapentin, 235 primary pulmonary hypertension see primary
Ehlers Danlos syndrome, 160 g-glutamyl-transpeptidase (GGT), pregnancy, pulmonary hypertension
intrahepatic cholestasis of pregnancy, 346 effects of, 249, 250, 258, 384 pulmonary arteriovenous malformations, 62
myasthenia gravis therapy, 154 Gardnerella vaginalis infection, 322 scleroderma, 418
FEV1 (forced expiratory volume in one second), gastrointestinal changes, end-stage renal sickling syndromes, 296
heart“lung transplantation, 388 disease, 383 spinal muscular atrophy see spinal muscular
fever gastrointestinal procedures, antibiotic atrophy (SMA)
bacterial infections, 321 prophylaxis, 5 Sturge“Weber disease/syndrome, 184
malignant hyperthermia, 271 Gaucher disease, 240“1 subarachnoid hemorrhage, 175
fiberoptic laryngoscopy, 122 gender differences syringomyelia, 205“6
fibrillation, ventricular see ventricular fibrillation cholinergic agents, 229 thromboembolic disease, 85
fibrillin-1 gene mutation, 65 long QT syndrome, 44 thyrotoxic crisis, 276
fibrin deposition, 297 nonsteroidal anti-inflammatory drugs, 229 Trypanosoma cruzi infection, 334
fibrinogen, pregnancy, effects of, 249, 250, 255, 293, opioids, 229 varicella zoster virus infection, 326
294, 384 general anesthesia gene therapy, cystic fibrosis, 90
fibrinogen deficiency, 298 acute fatty liver of pregnancy, 255 genetic counseling, congenital myotonic dystrophy,
types, 310 Addison disease, 285 103, 121“6
fibromyalgia, 232“4 alcohol abuse, 224 genitourinary antibiotic prophylaxis, 5
fifth disease see parvovirus B19 infection aortic dissection, 14 genotype“phenotype correlations, Marfan
FIGO staging, malignancy, 376 Arnold Chiari malformation, 185 syndrome, 65
FK506 see tacrolimus arthrogryposis multiplex congenita, 158, 159 geographical epidemiology, hepatitis C, 250, 264
flecainide, 38 asthma cesarean section, 80 German measles see rubella (German measles)
peripheral neuropathy, 224 benign intracranial hypertension, 178 germ cell cancer, 374
preexcitation syndrome therapy, 43 central nervous system tumors, 376 gestational thrombocytopenia see
flexible fiberoptic pharyngo-laryngoscopy, 409 Charcot“Marie“Tooth disease see thrombocytopenia
fludrocortisone, 285 Charcot“Marie“Tooth disease gestational trophoblastic disease (GTD), 376
fluid management Conn syndrome, 287 gestational trophoblastic neoplasia (GTN), 376
adult respiratory distress syndrome, 76 Cushing syndrome, 287 Gitelmann syndrome, 250, 264
aortic stenosis, 8 cystic fibrosis, 92 Glanzmann thrombasthenia (GT), 303, 306
intracerebral hemorrhage, 176 diabetes mellitus, 280 Glenn repair, 21, 30
intravenous fluid management, 180 disproportionate dwarfism, 110, 121“2 gliomas, 173
neurosurgery see neurosurgery Ehlers Danlos syndrome, 161 epidemiology, 375
porphyria therapy, 245 electroconvulsive therapy, 364, 368 globulins (serum), albumin ratio, 384
fluoroquinolones, 333 epilepsy, 170 a-globulins (serum), pregnancy, effects of, 250, 384
fluoroscopy, 60 factor V deficiency, 311 b-globulins (serum), pregnancy, effects of, 250, 384
fluoxetine, teratogenesis, 366 familial dysautonomia, 217 g-globulins (serum), pregnancy, effects of, 250, 384
flupentixol, 363 Friedreich ataxia, 157 globulins (serum), pregnancy, effects of, 249, 250,
fluphenazine, 363 Gaucher disease, 241 255, 384
focal necrotizing glomerulonephritis, 263 Gorlin disease, 145 glomerular filtration rate (GFR)
´
focal nodular hyperplasia, 255 Guillain“Barre syndrome, 218 chronic renal failure, 258
focal segmental glomerulosclerosis, 263 heart transplantation, anesthetic management, normal pregnancy, 258
folic acid supplements, 168 397 glomerulonephritis, 249, 250, 262, 263
Fontan repair, 20“1, 29 herpes simplex virus infection, 325 glucocorticoids
Food and Drug Administration (FDA) hydrocephalus with shunt, 178 Addison disease management, 285
analgesic drug grading, 233 hypertrophic obstructive cardiomyopathy, 13 systemic lupus erythematosus therapy, 412
antidysrhythmic drugs, 51, 52 hypoparathyroidism, 289 glucose
category B medications, 230 inflammatory myopathies, 110, 122 hypoglycemic coma management, 279
category C medications, 230 Laron dwarfism, 118 thyrotoxic crisis, 275




431
Index


glutamic oxaloacetic transaminase (GOT), 384 transesophageal echocardiography, 396 hemoglobin SS (Hb SS) see sickling syndromes
glutamic pyruvic transaminase (GPT), 384 volatile agents, 398 hemolysis, elevated liver enzymes and low platelets
glutathione S-transferase alpha, intrahepatic case reports, 388 (HELLP) syndrome, 307, 308
cholestasis of pregnancy, 253, 346 hemodynamic indices, 387“8 acute fatty liver of pregnancy, 254
glyceryl trinitrate see nitroglycerin obliterative bronchiolitis, 388 typhoid fever vs., 334
glycogen storage diseases, 104, 239“40 obliterative bronchiolitis syndrome, 388 hemolytic anemias, 296“7
glycolysis defects, 104 physiological effects, 387 hemolytic uremic syndrome (HUS), 249, 262,
glycopyrrolate, porphyria, 245 pregnancy, 382 307, 308
gold, rheumatoid arthritis therapy, 407 pulmonary function, 388 hemophilia A see factor VIII deficiency (hemophilia A)
Goodpasture syndrome, 250, 262 rejection, 388 hemophilia B see factor IX deficiency
Gorlin disease, 145, 146 statistics, 382 hemoptysis, 60
Gorlin“Golty syndrome see Gorlin disease see also heart transplantation hemorrhagic shock, 386
gradient estimation, aortic stenosis, 8 heart rate, 21, 29, 30 hemothorax, 60
¨
Graves disease atrial septal defect management, 17 Henoch“Schonlein purpura, 309
hyperthyroidism, 275 in heart transplant recipients, 387 heparin
maternal, thyroid disease in neonates, 277 mitral regurgitation/insufficiency, 9 American Society of Regional Anesthesiology
grey platelet syndrome (aSPD), 306, 308, 309“10 heart rhythm, pregnancy, effects of, 30 guidelines, 5
anesthesia, 307 heart sounds, 63 antiphospholipid syndrome, 419
growth hormone resistance, Laron dwarfism, 115 primary pulmonary hypertension, 57 cerebral ischemia therapy, 177
´
Guillain“Barre syndrome (GBS), 218 heart transplantation, 386“8 deep vein thrombosis management, 82“4
Guthrie test, phenylketonuria, 241 anesthetic management, 396“8 dosing regimens, 84
aseptic techniques, 382“3 hypercoagulable states, 314
hair growth, normal pregnancy, 345 dysrhythmias, 40“1 induced thrombocytopenia, 4
Hallopeau“Siemens syndrome, 348 hemodynamic indices, 387“8 during pregnancy, 4
haloperidol maternal complications, 386 pulmonary thromboembolism, 84
schizophrenia, 363 pathophysiology, 387 scoliosis, 137
teratogenesis, 363 peripartum cardiomyopathy, 11“12 thromboembolic disease, 85
halothane preconception considerations, 386“7 see also low molecular weight heparin (LMWH)
asthma, cesarean section, 80 pregnancy, 382, 387 hepatic adenoma, 255
cardiovascular effects, 2 see also heart“lung transplantation hepatic blood flow, 249, 255
HIV infection, 324 helper T cell balance, bacterial infections, 321 hepatitis A, 249, 254, 258“65
porphyria, 245 hemabate see prostaglandin F2-alpha hepatitis B, 249, 250, 256, 258“9
hantavirus pulmonary syndrome, 327“8 hemangioblastomas, 151 diagnosis, 250, 262
´
head and neck cancers, 375 hemangiolipomas, 196 Guillain“Barre syndrome, 218
heart abnormalities hemangiomas, 196, 197 incidence, 250, 262“4
Ehlers Danlos syndrome, 161 hematological diseases/disorders interferon therapy, 250, 262“3
systemic lupus erythematosus, 412“13 end-stage renal disease, 383 transmission, 250, 262“3
heart disease systemic lupus erythematosus, 410 hepatitis C, 249, 250, 256, 259
anesthetic management, 5“6 see also specific diseases/disorders geographical epidemiology, 250, 264
classification, 39 hematological malignancies, 377 HIV coinfection, 250, 264
clinical history, 2, 3“4 hematological matching, antiphospholipid incidence, 250, 263“4
disproportionate dwarfism, 125 syndrome, 419 liver function tests, 250, 264
dysrhythmias, 39 hematologic evaluation transmission, 250, 264
management, 3“6 Ehlers Danlos syndrome, 161 hepatitis D, 249, 250, 259“60
maternal mortality, 3 systemic lupus erythematosus, 413“14 hepatitis E, 249, 250, 260, 261
Noonan syndrome, 147 hematomas, 181 hepatitis G, 249, 250, 260“1, 263
postpartum period, 6, 7 spinal see spinal hematoma hepatocellular carcinoma, 255
invasive monitoring, 6 hemodynamics hepatolenticular degeneration (Wilson disease),
structural, 1“18 aortic stenosis, 8 249, 250, 251, 256
dysrhythmias, 40 atrial fibrillation, 37 hereditary angioedema, 353
incidence, 1 atrial flutter therapy, 37 hereditary chronic pancreatitis, 197
New York Heart Association classification, 1 cesarean section, 6 hereditary coproporphyria (HC), 242
see also specific diseases/disorders heart disease, 6 hereditary elliptocytosis, 297
tuberous sclerosis, 151 heart“lung transplantation, 387“8 hereditary hemorrhagic telangiectasia (HHT), 60,
vaginal vs. cesarean section delivery, 6 heart transplantation, 387“8 62, 309
heart disease, conduction disorders, 21, 29, 52 monitoring, 92 hereditary myopathies, 101“4
assessment, 21, 30“2 pheochromocytoma management, 284 hereditary neuropathy with liability to pressure
impulse generation, 29 pulmonary thromboembolism, 84 palsies (HNPP), 216“17
impulse propagation, 29 hemoglobin C homozygosity, 295 hereditary sensorimotor neuropathy (HSMN) type I
heart failure, Takayasu arteritis, 64 hemoglobin E homozygosity, 295 see Charcot“Marie“Tooth disease
heart lesions, cyanotic congenital see cyanotic hemoglobinopathies, 294, 295 hereditary sensorimotor neuropathy (HSMN) type II
congenital heart lesions see also specific diseases/disorders see Charcot“Marie“Tooth disease
heart“lung transplantation, 386“8 hemoglobin S (Hb S) hereditary sensorimotor neuropathy (HSMN)
anesthetic management, 396“8 Hb E combination, 295 type III, 216
aseptic techniques, 382“3 Hb F combination, 295 hereditary sensorimotor neuropathy (HSMN)
bronchoconstriction, 398 hemoglobin SC (Hb SC), 295 type IV, 216
invasive monitoring, 396 hemoglobin SD (Hb SD), 295 hereditary spherocytosis, 296“7




432
Index


hereditary stomatocytosis, 297 hypercholesterolemia, 389 management
Hermansky“Pudlak syndrome, 306 hypercoagulation, 314 levothyroxine, 277
herpes gestationis see pemphigoid of pregnancy thromboembolic disease, 81 thyroid replacement therapy, 277
herpes simplex virus (HSV) infection, 325 hyperemesis gravidarum, 251, 252 skeletal muscle effects, 277
dermatoses, 354 liver transplantation, 345, 385 subclinical, 277
hepatitis, 249, 261 transient hyperthyroidism, 275 trophoblastic disease, 377
type I, 325, 354 hyperglycemia, diabetic ketoacidosis hypotonia, 120
type 2, 325, 354 management, 279 hypoventilation, 134
highly active antiretroviral therapy (HAART), 324 hyperglycemic hyperosmolar state, 280 hypovolemia
hip replacements, 408 characteristics, 280 chronic renal failure, 259
histamine H2-receptor blockers hyperimmune globulin therapy, 325 heart transplantation, anesthetic
familial dysautonomia, 217 hyperkalemia management, 396
hyperemesis gravidarum management, 252 chronic renal failure, 259 hypoxemia
malignant hyperthermia, 269, 271 renal disease, 260 adult respiratory distress syndrome, 75
HIV infection, 323“5, 354 spinal cord injury, 195 amniotic fluid embolism, 88
´
Guillain“Barre syndrome, 218 hyperkalemic periodic paralysis, 108 pulmonary arteriovenous malformations, 59
hepatitis C coinfection, 250, 264 muscle weakness, 108, 119, 120 scoliosis, 134, 137
peripheral neuropathy, 222 hypermagnesemia venous air embolism, 85
platelet disorders, 303 chronic renal failure, 259
HLA typing, bone marrow failure syndromes, 299 myasthenia gravis, 154 ibuprofen, dosages, 232
HOCM see hypertrophic obstructive renal disease, 260 ICD see implantable cardiac defibrillator (ICD)
cardiomyopathy (HOCM) hyperparathyroidism, 275, 288“9 idiopathic aplastic anemia, 297“8
Hodgkin disease, 301 hyperpigmentation, 345 idiopathic facial (VII) nerve palsy, 219
incidence, 371 hyperserotoninergic state, 367 idiopathic/immune thrombocytopenic purpura
Holter monitor study, 34 hypertension (ITP), 303, 304
homocystinuria, 240, 242, 269“73 chronic renal failure, 259 idiopathic inflammatory myopathies, 357
Horder spots, Chlamydia psittaci infection, 334 cyclosporine, 391 idiopathic scoliosis see scoliosis
hormonal changes, epilepsy, 168 pheochromocytoma, 283 imaging, central nervous system disorders, 167
hormonal therapy, pulmonary pregnancy in kidney transplantation, 383 immunoglobulin A nephropathy,
lymphangioleiomyomatosis, 95 renal replacement therapy, 264 glomerulonephritis, 263
hospitalization scleroderma, 405, 416“17 immunosuppressive drugs, 389“93
acute asthma, 79 Takayasu arteritis, 64 anesthetic management in transplant
acute pneumothorax, 93 hyperthermia, malignant see malignant recipients, 394
hyperemesis gravidarum, 252 hyperthermia aplastic anemia, 297
human leukocyte antigen (HLA) typing, bone hyperthyroidism, 269, 270, 275“6, 288 congenital defects, 389
marrow failure syndromes, 299 see also thyrotoxic crisis (thyroid storm) monoclonal antibodies, 393
human papillomavirus infection, 325“6 hypertrophic obstructive cardiomyopathy (HOCM), myasthenia gravis therapy, 152, 153, 154
dermatoses, 354 12“13 peripartum cardiomyopathy, 11
vulvar cancer, 374 hyperventilation during pregnancy, 390, 395
humeral muscular dystrophy, 105 electroconvulsive therapy, 368 systemic lupus erythematosus therapy, 412
hydatid disease, 249, 257 malignant hyperthermia, 270, 271 transplantation, 389
hydralazine in pregnancy, 1 see also specific drugs
intravenous fluid management, 180 hyperviscosity, 18 immunotherapy, dermatoses, 351, 353
spinal cord injury, 193 hypervolemia, 180 impedance plethysmography, 82
hydrocephalus hypocalcemia correction, 350 impetigo herpetiformis see pustular psoriasis of
achondroplasia, 120 hypofibrinogenemia, 310 pregnancy
etiology, 178 hypoglycemic coma, 182, 279 implantable cardiac defibrillator (ICD)
spina bifida cystica, 203 clinical features, 279 arrhythmogenic right ventricular
subarachnoid hemorrhage, 174 etiology, 19 cardiomyopathy, 53
hydrocephalus with shunt, 178 incidence, 279 peripartum cardiomyopathy, 11
hydrocortisone insulinomas, 182 impulse generation, 29
Addison disease management, 285 management, 279 impulse propagation, 29
asthma labor/delivery, 80 hypokalemia, 46 inclusion-body myositis
status asthmaticus management, 79 hypomagnesemia, 46 dermatoses, 357
hydronephrosis, 1, 262 hypomania see manic depressive illness inflammatory myopathies, 110, 120
hydrops fetalis, 327 hyponatremia, 252 increased intracranial pressure management, 179
hydroxychloroquine hypoparathyroidism, 289 induced thrombocytopenia, 4
rheumatoid arthritis therapy, 407, 408 hypoprothrombinemia, 310 induction agents
systemic lupus erythematosus, 412 hypotension hypothyroidism, 277
21-hydroxylase deficiency, 287 amniotic fluid embolism, 88 infantile scoliosis, 129
5-hydroxytryptamine, 366 aortic stenosis, 8 infectious diseases, 321“42
hypercalcemia heart transplantation, 396 anesthetic management, 335
kidney transplantation, 383 hypertrophic obstructive cardiomyopathy, 13 central nervous system disorders, 173
presenting symptoms, 289 spinal cord injury, 194 emerging infections, 328
hypercarbia Takayasu arteritis, 64 peripheral neuropathy, 222
renal disease, 260 hypothermia, McArdle disease, 240 renal disease, 260
venous air embolism, 85 hypothyroidism, 276“7 transplantation, 389




433
Index


infectious diseases, (cont.) intravenous immunoglobulin (IVIg) anesthetic management, 394
tropical diseases, 323“8 myasthenia gravis therapy, 153, 154 optimum function, 395
see also specific infections rubeola in pregnancy, 327 preeclampsia, 49
infectious embolism, 89 intubation see endotracheal intubation see also specific diseases/disorders
infective endocarditis, 4 in-utero echocardiography, 4 see also pancreas“kidney transplantation
inflammation, bacterial infections, 321 invasive monitoring King“Denborough syndrome (King
inflammatory mediators, adult respiratory distress heart disease, 6 disease), 104
syndrome, 75 heart“lung transplantation anesthetic Klebsiella pneumoniae infection, post lumbar
inflammatory myopathies, 108“10 management, 396 puncture, 335
anesthetic management, 84 heart transplantation, anesthetic Klippel“Trenaunay“Weber syndrome (KTWS), 69,
dermatomyositis, 108, 119“20 management, 396 183, 184
extramuscular manifestations, 110 hypertrophic obstructive cardiomyopathy characteristics, 69
general anesthetic, 110, 122 management, 12 Kasabach“Merritt coagulopathy, 70
inclusion-body myositis, 110, 120 mitral regurgitation/insufficiency, 9 vascular abnormalities, 68“9
muscle strength monitoring, 110, 122 pulmonary thromboembolism, 82 VG5Q gene, 69
overlap syndrome, 110, 121“2 scoliosis, 138 Kugelberg“Welander disease (spinal muscular
polymyositis, 108, 120 Takayasu arteritis, 64 atrophy type III), 137, 197
therapy, 110 invasive venography, deep vein thrombosis, 82 kyphoscoliosis, 129
inflammatory pain, 229 iodide solutions, thyrotoxic crisis management, 276 achondroplasia, 120
123
infliximab, 353 iodinated metaiodobenzylguanidine scans, 284 Ehlers Danlos syndrome, 159
influenza, 327 ipratropium, 79 Friedreich ataxia, 156
inhaled nitric oxide, 22 ischemia, central nervous system disorders, 176“81 spina bifida cystica, 203
inheritance ischemic heart disease, 40 spinal muscular atrophy, 197, 198
cystic fibrosis, 89 isoflurane
Gorlin disease, 145 asthma cesarean section, 80 labetalol, 180
muscular dystrophies, 101, 107, 115“28 cardiovascular effects, 2 labetalol, pheochromocytoma, 284, 285
tuberous sclerosis, 149 cyclosporine interactions, 392 labor
inherited hemolytic anemias, 296“7 heart transplantation, 396 asthma see asthma
inherited renal disease, 250, 262“4 HIV infection, 324 dysrhythmias, 29
inlet atrioventricular (AV) canal, 17 porphyria, 245 scoliosis, 138
inotropes primary pulmonary hypertension, 59 labor pain, 1
heart transplantation, anesthetic isolated atrial septal defects, 16 lactate dehydrogenase (LDH), pregnancy, effects of,
management, 396 isolated growth hormone deficiency, 249, 250, 258, 384
peripartum cardiomyopathy, 11 101, 115 landiolol, Marfan syndrome, 68
primary pulmonary hypertension, 58 isoniazid large loop excision, 373
tetralogy of Fallot, 19 peripheral neuropathy, 224 Laron dwarfism, 101, 115“18
inspired volumes, scoliosis-pregnancy tuberculosis therapy, 332 Larsen syndrome, 126
interactions, 135 isoproterenol, 33 laryngeal cancer, therapy, 375
insulin, diabetic ketoacidosis management, 279 isotope scanning, 82 laryngoscopy, heart transplantation, anesthetic
insulinomas, 182 management, 396
intensive care, acute asthma management, 79 jaundice laser therapy
interferon alpha therapy acute fatty liver of pregnancy, 254 human papillomavirus infection, 326
essential thrombocytopenia, 300 liver transplantation, 384 tracheal stenosis, 94
thyroid disease effects, 277 Jervell, Lange“Nielsen syndrome, 44, 45 Lassa hemorrhagic fever, 335
interferon therapy, hepatitis B, 250, 262“3 latex allergy, spina bifida cystica, 204
interleukins, adult respiratory distress syndrome, 75 kala-azar, 334“5 laudanosine, epileptic effects, 170
intermediary metabolism disorders, 239“47 Kasabach“Merritt coagulopathy, 70 LEA see lumbar epidural analgesia (LEA)
see also specific diseases/disorders Katayama fever see schistosomiasis lead, peripheral neuropathy, 223
interstitial lung disease, 95 Kawasaki disease, 69 lead palsy, 223
intracerebral hematomas, 181 KCNE1 gene, 45 leflunomide, 407
intracerebral hemorrhage, 174, 175“6 KCNQ1 gene, 45 left anterior fascicular blocks, 33
intracranial lesions, 168 Kennedy disease, 200 left bundle branch block (LBBB), 33
intracranial pressure (ICP) ketamine left cervicothoracic sympathectomy, 46,
central nervous system tumors, 375 asthma, 79 47, 49
prolactinoma, 280 bacterial infections, 321“3 left uterine displacement, amniotic fluid embolism
intracranial pressure (ICP), increased, 178“80 cardiovascular effects, 2 management, 88
analgesia, 175, 179 fibromyalgia, 234 left ventricular end diastolic volume (LVEDV), 8
anesthesia, 179, 180“1 myasthenia gravis, 155 leishmaniasis, 334“5
segmental lumbar epidural anesthesia, Parkinson disease, 172 leprosy, 222
176, 180 post cesarean section pain, 234, 235 Leptospira infections, 330
intrahepatic cholecystitis of pregnancy, 345 renal failure effects, 261 leukemias, 301
intrahepatic cholestasis of pregnancy, 249“53, 345“7 viral hepatitis, 252 anesthetic management, 302
differential diagnosis, 345, 347, 390 ketoconazole, 287 cesarean section, 302
intrathecal opioids, 139 see opioids kidney dialysis see renal replacement therapy incidence, 301, 371
intrauterine growth restriction, asthma, 77 (dialysis) leukotriene modifiers, 78
intravascular volume assessment, renal disease, 260 kidney disease see renal disease/disorders leukotriene receptor antagonists, 78
intravenous access, Ehlers Danlos syndrome, 161 kidney transplantation, 381“4 levobupivacaine, 235




434
Index


levodopa American Society of Regional Anesthesiology myopathies, 110
Parkinson disease therapy, 171 guidelines, 5 neurofibromatosis type 1“18, 148“9
side effects, 171 deep vein thrombosis management, 84 see also specific tumors/cancers
levothyroxine, 277 dosage, 84 malignant hyperthermia, 240, 269“73
lichen planus pemphigoides (LPP), 348 dosage, renal failure effects, 261 thyrotoxic crisis vs., 275
lidocaine, 52 hypercoagulable states, 314 malignant melanoma, 352, 377
asthma, 79 during pregnancy, 4 ABCDE markings, 351
cardiovascular effects, 2 valvulotomy, 10 anesthetic management, 352
epileptic effects, 170 lumbar disc prolapse, 141 incidence, 345, 351, 371
pheochromocytoma, 284 lumbar epidural analgesia (LEA) risk factors, 352
premature ventricular depolarization, 34 arthrogryposis multiplex congenita, 158 malpresentation
Takayasu arteritis, 65 cystic fibrosis, 92 Ehlers Danlos syndrome, 160
ventricular tachycardia, 39 increased intracranial pressure, 176, 180 scoliosis, 138
life expectancy, transplantation, 381 neurofibromatosis, 149 manic depressive illness, 364“8
ligamentous laxity Noonan syndrome, 147 management see specific drugs/medications
pubic pain, 231 scoliosis, 140 mannitol, intracranial pressure, 179
rheumatoid arthritis, 408 Sturge“Weber disease/syndrome, 184 Marburg hemorrhagic fever, 335
limb girdle muscular dystrophy, 104, 105 tuberous sclerosis, 151 Marfan syndrome (MFS), 65“9
linear IgA dermatosis, 348 lumbar puncture, infectious diseases, 335 aortic dissection, 13
lipid metabolism disorders, 104“8 lumbosacral plexus injury, 219“20 Marshall“Smith syndrome, 126
lipomas, 196 lung cancer, 377 mastocytosis, 343
Listeria monocytogenes infection, 322 lung diseases/disorders see under pulmonary; cutaneous, 343, 353“9
transplant recipients, 389 specific diseases signs and symptoms, 359
lithium, 365 lung surfactant, 76 systemic, 359
Ebstein anomaly, 365 lung transplantation diagnosis, 359
peripheral neuropathy, 224 cystic fibrosis therapy, 90 signs and symptoms, 343, 359
lithotomy position, peripheral neuropathy primary pulmonary hypertension therapy, 58 maternal Graves disease, thyroid disease in
prevention, 225 Lyell syndrome see toxic epidermal necrolysis (Lyell neonates, 277
Little People of America, 115 syndrome) maternal hydrops, 314“15
live birth rate Lyme disease, 350 maternal mortality see mortality
chronic renal failure, 259 lymphangioleiomyomatosis (LAM), 150, 151 maternal thrombocytopenia, Gaucher disease, 241
renal disease, 259 lymphocytic hypophysitis, 282 May“Hegglin anomaly, 293, 303, 305“6
livedo reticularis (LR), 352 lymphomas, 301 cesarean section, 306
liver biopsy, intrahepatic cholestasis of pregnancy, 346 anesthetic management, 302 general anesthesia, 306
liver disease, 249“58, 272 lyonization effects, factor VIII deficiency, 312 McArdle disease, 239, 240
see also specific diseases/disorders lysosomal storage disorders, 240“1 MDMA toxicity, malignant hyperthermia vs., 269, 271
liver function tests see also specific diseases/disorders mean cell volume (MCV), pregnancy, effects of, 294
hepatitis C, 250, 264 measles see rubeola (measles)
normal pregnancy, 249, 250, 254 M1 antagonists, heart transplantation, 396 measles, German see rubella (German measles)
liver“kidney transplants, 382 M2 antagonists, heart transplantation, 396 measles, mumps, and rubella vaccine, 327
liver rupture, 249, 257 macroadenomas, 280 mebendazole, 257
liver transplantation, 384“6 macrolide antibiotics, 334 mechanical ventilation
anesthetic management, 394“6 magnesium Charcot“Marie“Tooth disease, 216
hepatolenticular degeneration, 256 chronic depletion, 41 pulmonary thromboembolism, 84
hyperemesis gravidarum, 345, 385 dysrhythmias, 41 medical history
pregnancy, 382 magnesium sulfate anesthetic management in transplant recipients, 393
statistics, 382 cardiovascular effects, 2 coma, 182
liver tumors, 249, 255 chronic spinal cord injury, 192 medicolegal implications, coma, 182
lobular capillary hemangioma, 352“3 pheochromocytoma, 288“9 mefloquine, 331
local anesthesia seizure disorders management, 168 melanoma, malignant see malignant melanoma
fibromyalgia therapy, 233 spinal cord injury, 194 membrane disorders, hemolytic anemias, 296
post cesarean section pain therapy, 235 magnetic resonance imaging (MRI) membrane pemphigoid, 348
pubic pain therapy, 232 central nervous system disorders, 167 membranous nephropathy, 263
see also specific types deep vein thrombosis diagnosis, 82 MEN see multiple endocrine neoplasia (MEN)
long-chain 3-hydroxyacyl-CoA dehydrogenase intracerebral hemorrhage diagnosis, 175 meningiomas, 173
(LCHAD) deficiency, acute fatty liver of lumbar disc prolapse, 141 epidemiology, 375
pregnancy, 254 Marfan syndrome, 67 spinal cord tumors see spinal cord tumors
long QT syndrome (LQTS), 29, 44“9 pheochromocytoma diagnosis, 284 meningitis, 335
losartan, Marfan syndrome management, 66 pituitary gland disorders, 280 meningocele, 202
Lou“Gehrig disease see amyotrophic lateral sclerosis spina bifida occulta, 202 mental retardation, cytomegalovirus infection, 325
(ALS) spinal cord tumors, 195 meperidine
low birthweights, scoliosis, 136 tethered cord syndrome, 206 cardiovascular effects, 2
low-dose local anesthetic, peripheral neuropathy major histocompatibility complex class II (MHC dosages, 232
prevention, 225 class II), pemphigoid of pregnancy, 347 renal failure effects, 261
lower limb neuropathies see neuropathies, lower malaria, 330“1 epileptic effects, 170
limb malar rash, systemic lupus erythematosus, 410 porphyria therapy, 245
low molecular weight heparin (LMWH) malignancy, 371“9 spinal cord injury, 194




435
Index


meralgia paresthetica, 220, 235 monkeypox infection, 328 Mustard procedure, 21, 32
mercury, peripheral neuropathy, 223 monoamine oxidase inhibitors (MAOIs), 367 transposition of the great vessels, 40
mesangiocapillary glomerulonephritis, 263 type B mutations
mesodermal spina bifida occulta, 202 panic disorder therapy, 369 Friedreich ataxia, 155
metabolic abnormalities Parkinson disease therapy, 171 Gorlin disease, 145
hemolytic anemias, 296 monoclonal antibodies, immunosuppressive drugs, hepatolenticular degeneration, 256
see also specific diseases/disorders 393 long QT syndrome, 44
metabolic acidosis, chronic renal failure, 259 monomelic amyotrophy, 200 Parkinson disease, 170

<< . .

 85
( 87)



. . >>

Copyright Design by: Sunlight webdesign